Factors influencing locoregional recurrence rates in locally advanced rectal cancer after total neoadjuvant treatment versus chemoradiotherapy in the RAPIDO trial
British Journal of Surgery · 02.09.2025 · 112 (9)
DOI: 10.1093/bjs/znaf190 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift British Journal of Surgery, online erschienen am 29.09.2025. Verfasst von Ilaria Prata und 15 weiteren Autor:innen. Beteiligte Einrichtung: GROW, School for Oncology and Reproduction, Maastricht University, Maastricht, The Netherlands. Hauptthemen laut MEDLINE: Rectal Neoplasms, Neoadjuvant Therapy, Neoplasm Recurrence, Local, Chemoradiotherapy. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: Swedish Cancer Society; the Swedish Research Council, Spanish Ministry of Economy and Competitiveness through the Carlos III Health Institute, Spanish Clinical Research Network.
Abstract (Originalsprache)
Background
The RAPIDO trial compared total neoadjuvant treatment (TNT) with preoperative chemoradiotherapy (CRT), both followed by total mesorectal excision, in patients with locally advanced rectal cancer (LARC). A higher locoregional recurrence (LRR) rate was observed after TNT. This study investigates factors contributing to the difference in LRR observed.
Method
Patients with high-risk LARC received TNT (5 × 5 Gy followed by 6 × CAPOX or 9 × FOLFOX4) or CRT (25–28 × 1.8–2 Gy with concurrent capecitabine). Patients with a local R0 or R1 resection were included in this study. Sphincter-preserving surgery encompassed (low) anterior resection and Hartmann’s procedure. The influence of baseline, surgical and pathological factors on LRR was evaluated.
Results
Of 920 randomized patients, 849 (430 versus 419 in the TNT and CRT arms) were eligible. The cumulative incidence of LRR at 8 years was 10.8% after TNT and 5.8% after CRT (HR 1.91). Following sphincter preserving surgery, 12.1% (TNT) and 4.8% (CRT) developed LRR (HR 2.60), compared to 8.5% versus 7.5%, respectively, after abdominoperineal resection. Distal resection margin rates (DRM) of 10 mm or less after sphincter-preserving surgery were similar in both arms (TNT 17.5% versus CRT 22.1%). However, a higher cumulative incidence of LRR was observed with a DRM of 10 mm or less after TNT (25.4% versus 1.8%; HR 15.51). Other factors were similar between treatment arms with respect to LRR.
Conclusion
The difference in LRR between TNT and CRT mainly occurred in patients treated with sphincter-preserving surgery. Baseline information on the original tumour bed should be considered when determining the surgical approach after total neoadjuvant treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- GROW, School for Oncology and Reproduction, Maastricht University, Maastricht, The Netherlands.
- Department of Surgery, Netherlands Cancer Institute, Amsterdam, The Netherlands.
- Department of Surgery, Leiden University Medical Centre, Leiden, The Netherlands.
- Department of Radiation Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
- Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
- Department of Pathology, Radboud University Medical Centre, Nijmegen, The Netherlands.
ORCID-Profile: Hein Putter, Per J Nilsson
Förderung
- Swedish Cancer Society; the Swedish Research Council
- Spanish Ministry of Economy and Competitiveness through the Carlos III Health Institute
- Spanish Clinical Research Network
- European Union's Horizon 2020 research and innovation
- European Regional Development Fund
- European Union’s Horizon 2020 research and innovation
Zitieren
APA
Prata, I., Tanaka, M. D., Glimelius, B., Nagtegaal, I. D., Beets-Tan, R. G. H., Blomqvist, L. K., Couwenberg, A. M., van Etten, B., Hospers, G. A. P., Meershoek-Klein Kranenbarg, E., Peeters, K. C. M. J., Putter, H., Roodvoets, A. G. H., van de Velde, C. J. H., Nilsson, P. J., & Marijnen, C. A. M. (2025). Factors influencing locoregional recurrence rates in locally advanced rectal cancer after total neoadjuvant treatment versus chemoradiotherapy in the RAPIDO trial. British Journal of Surgery, 112(9). https://doi.org/10.1093/bjs/znaf190
Vancouver
Prata I, Tanaka MD, Glimelius B, Nagtegaal ID, Beets-Tan RGH, Blomqvist LK, et al. Factors influencing locoregional recurrence rates in locally advanced rectal cancer after total neoadjuvant treatment versus chemoradiotherapy in the RAPIDO trial. British Journal of Surgery. 2025;112(9). doi:10.1093/bjs/znaf190
BibTeX
@article{Prata2025,
author = {Prata, Ilaria and Tanaka, Max D and Glimelius, Bengt and Nagtegaal, Iris D and Beets-Tan, Regina G H and Blomqvist, Lennart K and Couwenberg, Alice M and van Etten, Boudewijn and Hospers, Geke A P and Meershoek-Klein Kranenbarg, Elma and Peeters, Koen C M J and Putter, Hein and Roodvoets, Annet G H and van de Velde, Cornelis J H and Nilsson, Per J and Marijnen, Corrie A M},
title = {Factors influencing locoregional recurrence rates in locally advanced rectal cancer after total neoadjuvant treatment versus chemoradiotherapy in the RAPIDO trial},
journal = {British Journal of Surgery},
year = {2025},
volume = {112},
number = {9},
doi = {10.1093/bjs/znaf190}
}
EUVIMED